Delivery Order SPE2DB22D2009-SPE2DB25FM1MA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $10,415.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with performance to be completed by August 14, 2025, at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,074.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 160 mg capsules (100-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded and represents a discrete delivery order issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $1,469.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of July 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,935.69 firm fixed-price delivery order is for the supply of 4,567,021,550 units of the medication Propranolol ER 80 mg capsules. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $6,914.99 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,567,906,451 units of Propranolol ER 80 mg capsules. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,392,715 units of Propranolol ER 120 mg capsules in 100-count bottles. The contract has a total ceiling value of $7,150.54 and was awarded on August 8, 2024, with an ultimate completion date of August 9, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.82 firm fixed-price delivery order is for the supply of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Propranolol 10 mg tablets in quantities of 100, with a ceiling value of $1,088.55 and a firm fixed price structure. This non-set-aside competitive award is set for ultimate completion on September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This delivery order, valued at $2,328.44, awards AmerisourceBergen Drug Corp the supply of 1,000 tablets of Propranolol 20 mg for the Defense Logistics Agency (DLA). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical distributor will perform this work from its corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is issued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,853,432 units of Propranolol ER 160 mg capsules. The $3,312.34 firm fixed-price contract has an ultimate completion date of August 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1MADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) with a ceiling value of $2,301.91. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical support to defense and civilian government healthcare systems globally. This delivery order represents a routine execution of AmerisourceBergen's prime vendor contract, through which the company supplies a diverse portfolio of medications and medical commodities across multiple therapeutic domains to support military healthcare programs. The contract demonstrates the vendor's capability to fulfill federal pharmaceutical procurement requirements through competitive award mechanisms. As a child contract under the larger SPE2DX vehicle, this delivery order exemplifies the Defense Logistics Agency's strategy of leveraging prime vendor relationships to ensure efficient distribution of critical pharmaceutical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/12/25 |